Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of Iron Oligosaccharide in CKD Patients Needing Parenteral Iron
NCT00536666Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- May 2007
- Primary completion
- Aug 2008
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Pharmacosmos. Started May 2007; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00536666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536666.